Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70518-3850

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70518-3850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B4ff12a6 841e 4eff B9a4 Bb814230eea5 01)

Image (B4ff12a6 841e 4eff B9a4 Bb814230eea5 01)
Chemical structure of esomeprazole magnesium, showing the molecular arrangement including methoxy groups, sulfoxide moiety, and magnesium ion complexed with three water molecules.*
FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B4ff12a6 841e 4eff B9a4 Bb814230eea5 02)

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B4ff12a6 841e 4eff B9a4 Bb814230eea5 02)
A line graph depicting the percentage of esomeprazole magnesium delayed-release capsule content maintained over a 6-month period. Four groups are plotted: three different sample sizes of 40 mg capsules and a placebo, showing varying retention rates with the esomeprazole groups maintaining higher percentages compared to the placebo, which declines rapidly.*
FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B4ff12a6 841e 4eff B9a4 Bb814230eea5 03)

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B4ff12a6 841e 4eff B9a4 Bb814230eea5 03)
A line graph depicting the percent maintained over months (from 0 to 6) for Esomeprazole Magnesium Delayed-Release Capsules at doses of 40 mg, 20 mg, and 10 mg, compared to placebo. The 40 mg dose maintains near 100% throughout, with lower percentages maintained at 20 mg and 10 mg doses, and placebo showing the lowest maintenance over time.*
FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B4ff12a6 841e 4eff B9a4 Bb814230eea5 04)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B4ff12a6 841e 4eff B9a4 Bb814230eea5 04)
A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: esomeprazole magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The graph shows trends of increasing symptom-free patients over time for both 40 mg and 20 mg doses compared to placebo.*
FDA Label Image

Image (B4ff12a6 841e 4eff B9a4 Bb814230eea5 05)

Image (B4ff12a6 841e 4eff B9a4 Bb814230eea5 05)
A line graph showing the percent of patients symptom-free over 28 diary days. The graph compares esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses, and a placebo group, illustrating changes in symptom-free percentages during the study period.*
FDA Label Image

Mm1 (Esomeprazole Magnesium 40mg 70518 3850 00)

Mm1 (Esomeprazole Magnesium 40mg 70518 3850 00)
Label for Esomeprazole Magnesium 40 mg delayed-release capsules, package of 30 capsules. The label includes the NDC number 70518-3850-00 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions specify 20-25°C (68-77°F) with permitted excursions to 15-30°C (59-86°F). Manufacturer is Biocon Pharma, Iselin, NJ. The label notes "RX ONLY."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.